Clinical trials
Phase 3 Hematologic Neoplasms trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| Amgen | 1 |
| Bristol-Myers Squibb | 1 |
| Kura Oncology, Inc. | 1 |
| Merck Sharp & Dohme LLC | 1 |
| NHS Blood and Transplant | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 7 |
| Bone Marrow Diseases | 2 |
| Leukemia | 2 |
| Blood Protein Disorders | 1 |
| Bone Diseases | 1 |
| Bone Neoplasms | 1 |
| Fractures, Bone | 1 |
| Hematologic Diseases | 1 |
| Hemorrhage | 1 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.